JIA in 2011: New takes on categorization and treatment.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22231236.
- Also identified by DOI 10.1038/nrrheum.2011.198.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 2011, new treatment recommendations for juvenile idiopathic arthritis (JIA) were proposed, inroads were made towards understanding the heterogeneity of this disease, and data were presented demonstrating the potential efficacy of DMARD combination therapies for JIA treatment. These advances hold promise for improved management of JIA in 2012 and beyond.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Juvenile